Physician profile
Peter Ottavio
NPI 1093750028
$268,653.48
in general payments reported to CMS, 2019-2025
39 companies · $47K in 2025
The $47K reported for 2025 was more than what 97% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,042 · 2020: $15K · 2021: $41K · 2022: $61K · 2023: $52K · 2024: $53K · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $81K · Consulting Fee: $38K · Food and Beverage: $15K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $8,040 · Travel and Lodging: $7,459 · Education: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $81,260.00 |
| Consulting Fee | $38,435.00 |
| Food and Beverage | $15,401.75 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $8,040.00 |
| Travel and Lodging | $7,459.13 |
| Education | $465.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $252,190.77 | 2020-2025 | Wakix |
| Glaxosmithkline, LLC. | $3,326.06 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $2,426.84 | 2019-2025 | Tezspire, Airsupra, Breztri |
| Jazz Pharmaceuticals INC. | $1,396.64 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,356.30 | 2019-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,073.88 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Mylan Specialty L.P. | $941.78 | 2019-2024 | Yupelri, Yupelri |
| Amgen INC. | $795.47 | 2022-2025 | Tezspire |
| Insmed, INC. | $678.15 | 2022-2025 | Arikayce, Brinsupri |
| Genzyme Corporation | $615.91 | 2021-2025 | |
| Philips North America LLC | $566.56 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Actelion Pharmaceuticals US, INC. | $257.19 | 2022-2025 | Uptravi, Opsumit |
| Verona Pharma, INC. | $242.02 | 2025 | Ohtuvayre |
| Baxter Healthcare | $231.10 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System |
| Electromed, INC. | $217.55 | 2019-2025 | Smartvest |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $196.19 | 2024-2025 | Glassia |
| Merck Sharp & Dohme LLC | $191.24 | 2019-2025 | Belsomra, Pifeltro, Capvaxive |
| Teva Pharmaceuticals USA, INC. | $185.91 | 2020-2022 | |
| Viatris Specialty LLC | $167.12 | 2025 | Yupelri |
| Sunovion Pharmaceuticals INC. | $164.84 | 2019-2020 | |
| Genentech USA, INC. | $158.46 | 2022-2025 | Xolair |
| Grifols USA, LLC | $149.74 | 2021-2025 | Prolastin-C Liquid |
| Boston Scientific Corporation | $148.39 | 2025 | Watchman Flx |
| Melinta Therapeutics, LLC | $145.24 | 2024-2025 | Kimyrsa, Rezzayo, Orbactiv |
| Olympus America INC. | $144.45 | 2024 | Spin Vision Video Processor |
| Intuitive Surgical, INC. | $128.88 | 2024 | |
| Gilead Sciences, INC. | $73.44 | 2021-2025 | |
| Pfizer INC. | $67.97 | 2025 | |
| Novartis Pharmaceuticals Corporation | $51.96 | 2023-2024 | |
| Axsome Therapeutics, INC. | $51.61 | 2024 | Sunosi |
| Lilly USA, LLC | $48.90 | 2025 | Zepbound |
| United Therapeutics Corporation | $47.91 | 2025 | Tyvaso |
| Inspire Medical Systems, INC. | $45.96 | 2025 | Inspire |
| Idorsia Pharmaceuticals US INC | $38.90 | 2023 | Quviviq |
| Paratek Pharmaceuticals, INC. | $38.54 | 2025 | Nuzyra |
| Aimmune Therapeutics, INC. | $28.60 | 2025 | Vowst |
| Eisai INC. | $23.27 | 2022 | |
| Fisher & Paykel Healthcare INC | $22.06 | 2021 | |
| Amneal Pharmaceuticals LLC | $17.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Ottavio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.